Detalles de la búsqueda
1.
Can Observational Analyses of Routinely Collected Data Emulate Randomized Trials? Design and Feasibility of the Observational Patient Evidence for Regulatory Approval Science and Understanding Disease Project.
Value Health
; 26(2): 176-184, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970705
2.
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.
Pharmacoepidemiol Drug Saf
; 32(1): 44-55, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36215113
3.
Assessing the use of observational methods and real-world data to emulate ongoing randomized controlled trials.
Clin Trials
; 20(6): 689-698, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589143
4.
Equity of the HIV epidemic response in 13 African countries.
Afr J AIDS Res
; 22(4): 276-289, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38117740
5.
Machine Learning Methods in Health Economics and Outcomes Research-The PALISADE Checklist: A Good Practices Report of an ISPOR Task Force.
Value Health
; 25(7): 1063-1080, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35779937
6.
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force.
Value Health
; 25(10): 1663-1672, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36241338
7.
Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials.
BMC Med
; 19(1): 307, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34865623
8.
Decomposition analysis as a framework for understanding heterogeneity of treatment effects in non-randomized health care studies.
Pharm Stat
; 20(5): 945-951, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33724684
9.
Assessing and communicating heterogeneity of treatment effects for patient subpopulations: Panel discussion on considerations in design and analysis.
Pharm Stat
; 20(5): 952-964, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33118319
10.
Relative Cost Differences of Initial Treatment Strategies for Newly Diagnosed Opioid Use Disorder: A Cohort Study.
Med Care
; 58(10): 919-926, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32842044
11.
Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
Value Health
; 23(9): 1128-1136, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32940229
12.
Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative.
Pharmacoepidemiol Drug Saf
; 29(11): 1504-1513, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32924243
13.
Real-World Evidence, Causal Inference, and Machine Learning.
Value Health
; 22(5): 587-592, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31104739
14.
Application of Constrained Optimization Methods in Health Services Research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force.
Value Health
; 21(9): 1019-1028, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30224103
15.
How Can We Make More Rapid Progress in the Leveraging of Real-World Evidence by Regulatory Decision Makers?
Value Health
; 25(2): 167-170, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35094788
16.
Constrained Optimization Methods in Health Services Research-An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force.
Value Health
; 20(3): 310-319, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28292475
17.
Real-World Evidence: Understanding Sources of Variability Through Empirical Analysis.
Value Health
; 24(1): 116-117, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33431144
18.
Potential application of machine learning in health outcomes research and some statistical cautions.
Value Health
; 18(2): 137-40, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773546
19.
Applying dynamic simulation modeling methods in health care delivery research-the SIMULATE checklist: report of the ISPOR simulation modeling emerging good practices task force.
Value Health
; 18(1): 5-16, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25595229
20.
Selecting a dynamic simulation modeling method for health care delivery research-part 2: report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force.
Value Health
; 18(2): 147-60, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773550